Largest pharmaceutical companies in the United States by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Pfizer leads the 44 pharmaceutical companies in the United States ranked by net assets, at £66B, ahead of Johnson & Johnson (£62.2B) and Merck & Co (£40.1B). Figures as of 20 Nov 2026, 12:40 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
44
First
Pfizer£66B
Median
£498.7M
Combined market value
£2.85T
Countries
1

Market values as of .

United States
All sectors
Pharmaceuticals
GBP
Clear filters
Largest pharmaceutical companies in the United States by net assets
#CompanyNet assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1PfizerPFE · Health Care£66B£119.8B£21.02 1.85% down 10% up United States
2Johnson & JohnsonJNJ · Health Care£62.2B£490.8B£203.88 2.04% down 31% up United States
3Merck & CoMRK · Health Care£40.1B£249.9B£101.36 3.61% down 36% up United States
4Abbott LaboratoriesABT · Health Care£39.8B£137.3B£79.27 0.58% down 19% down United States
5Regeneron PharmaceuticalsREGN · Health Care£23.9B£72.9B£704.70 2.35% down 22% up United States
6Eli LillyLLY · Health Care£20.3B£918.5B£1,031.19 2.29% down 28% up United States
7Vertex PharmaceuticalsVRTX · Health Care£14.2B£100.7B£397.37 2.94% down 22% up United States
8Bristol-Myers SquibbBMY · Health Care£14.1B£91B£44.53 2.05% down 26% up United States
9ViatrisVTRS · Health Care£11.2B£17.4B£15.17 1.97% down 90% up United States
10Royalty PharmaRPRX · Health Care£7.4B£29.7B£51.68 1.38% down 74% up United States
11United TherapeuticsUTHR · Health Care£5.4B£18.2B£426.71 3.16% down 18% up United States
12Elanco Animal HealthELAN · Health Care£5B£10B£20.06 1.54% down 18% up United States
13BioMarin PharmaceuticalBMRN · Health Care£4.6B£9.1B£46.88 0.02% down 12% up United States
14ZoetisZTS · Health Care£2.5B£25.1B£61.66 5.59% down 34% down United States
15Ligand PharmaceuticalsLGND · Health Care£776.3M£4.4B£219.00 3.94% down 44% up United States
16Legend BiotechLEGN · Health Care£764.8M£2.4B£12.29 0.92% down 43% down United States
17Praxis Precision MedicinesPRAX · Health Care£670.2M£6.6B£237.28 1.87% up 83% up United States
18Alnylam PharmaceuticalsALNY · Health Care£602.3M£15.1B£112.82 1.06% down 66% down United States
19Belite BioBLTE · Health Care£588M£4.7B£115.26 3.33% down 25% up United States
20InsmedINSM · Health Care£564M£24.2B£110.25 20.58% up 27% down United States
21Spyre TherapeuticsSYRE · Health Care£545.9M£7.1B£74.51 3.77% down 302% up United States
22Summit TherapeuticsSMMT · Health Care£502.8M£6.5B£8.07 0.67% up 35% down United States
23TG TherapeuticsTGTX · Health Care£494.6M£7.5B£49.52 1.88% down 103% up United States
24Corcept TherapeuticsCORT · Health Care£494.4M£5.4B£49.59 4.15% down 16% down United States
25Cogent BiosciencesCOGT · Health Care£485.7M£3.7B£21.17 0.25% down 25% down United States
26Protagonist TherapeuticsPTGX · Health Care£469.2M£6.2B£94.65 2.47% down 45% up United States
27Madrigal PharmaceuticalsMDGL · Health Care£460M£7B£302.80 0.34% down 28% down United States
28Edgewise TherapeuticsEWTX · Health Care£398.6M£3.4B£31.42 0.48% down 82% up United States
29Dianthus TherapeuticsDNTH · Health Care£376.6M£3.6B£64.74 1.01% up 105% up United States
30Ionis PharmaceuticalsIONS · Health Care£373.3M£3.5B£20.77 0.62% down 64% down United States
31Oruka TherapeuticsORKA · Health Care£360.2M£5.1B£74.47 1.91% up 233% up United States
32Arrowhead PharmaceuticalsARWR · Health Care£355.7M£4.7B£33.31 1.25% up 8% up United States
33Definium TherapeuticsDFTX · Health Care£253.6M£3.1B£22.50 1.24% up 176% up United States
34ErascaERAS · Health Care£248.2M£3.8B£10.85 3.34% up 387% up United States
35Mirum PharmaceuticalsMIRM · Health Care£240.2M£4.8B£72.89 3.27% up 35% up United States
36Rhythm PharmaceuticalsRYTM · Health Care£106.1M£6.2B£89.14 1.88% down 15% up United States
37Travere TherapeuticsTVTX · Health Care£87.6M£3.5B£36.86 3.86% down 39% up United States
38Axsome TherapeuticsAXSM · Health Care£67.4M£5.4B£103.55 1.25% up 9% down United States
39Amneal PharmaceuticalsAMRX · Health Care-£54M£5.7B£16.33 2.24% down 79% up United States
40VeradermicsMANE · Health Care-£92.4M£4B£94.94 0.38% down 230% up United States
41PTC TherapeuticsPTCT · Health Care-£156.7M£3.7B£44.51 3.16% down 26% down United States
42CytokineticsCYTK · Health Care-£503.4M£5.5B£39.27 0.27% up 21% down United States
43BridgeBio PharmaBBIO · Health Care-£1.6B£11.6B£59.67 0.22% up 15% up United States
44AbbVieABBV · Health Care-£2.5B£382.5B£216.40 0.86% down 20% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.7632 GBP).

Questions and answers

Which pharmaceutical companies in the United States rank first by net assets?

Pfizer (£66B), Johnson & Johnson (£62.2B) and Merck & Co (£40.1B) are the top three of the 44 pharmaceutical companies in the United States ranked by net assets as of 20 Nov 2026, 12:40 UTC.

How many pharmaceutical companies in the United States are in this ranking?

44 are ranked by net assets.

What are these pharmaceutical companies in the United States worth together?

The 44 pharmaceutical companies in the United States ranked by net assets have a combined market value of £2.85T as of 20 Nov 2026, 12:40 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest pharmaceutical companies in the United States by net assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.